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GIANT	HEPATIC	HEMANGIOMAS
ANALYSIS OF PRESENTATION,  MANAGEMENT AND
OUTCOME – A SINGLE CENTER EXPERIENCE.
Department of Surgical Gastroenterology, Center of Excellence for Upper GI Surgery,
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Background:Hemangiomas represents a congenital,  hamartomatous proliferation (Non –neoplastic ) of vascular origin,  arising from mesodermal layer. Its etiologyremains idiopathic,  with the liver being the most common visceral organaffected. Majority of the cases are of a incidental discovery rather than aattempted search for the lesion. Therefore the natural history of thehemangioma are often asymptomatic and persists throughout the lifespan ofthe patient .
Only less than 10% of the lesions become symptomatic, and come for clinicalattention . Within this a small percentage  can meet with complications,particularly in those where the  lesion is quite large, of the order of more than10cm.
Management options are varied ranging from simple observation to
interventions like resection, eunucleation, hepatic artery ligation and liver
transplantation ,besides non operative procedures like angio embolisation,
radiation therapy, and  recently molecular target agents like Sorafenib ,
bevacizumab and so on .
Aim:
To study the different modes of presentation, gender predilection,
symptomatology,  complications,  various management modalities, outcome of the
varsious treatment strategies, in patients with Giant Cavernous symptomatic
Hepatic Hemangioma ,who were admitted in our center, between  march 2012 to
2014.
Materials and methods:
Only those cases of hemangioma liver who were persistenly symptomatic,and
those presenting with complications , were included in this retrospective
analysis. A total of eleven such patients were listed in this series(2012 -2014).
Asymptomatic ,incidentally diagnosed hemangioma liver were excluded
from this analysis.
Variables analysed in this study:
Gender differences, Average size, Predominant symptom, Imaging
modality employed, Predominant mode of intervention (resection or eunucleation
anatomical or nonanatomical resection) ,Morphology of the tumour, Peroperative
and Post operative parameters ,Duration of post operative stay and Mortality
were analysed in this study.
Results:
Age incidence in this analysis ranged between 22 and 60 yrs, with amedian age of 40yrs. Predominantly occurring in the female gender (90.9%),but no chronic OCP usage, or any exogenous hormonal intake were found inthis study.
Majority of the lesions were in the Lt lobe(66.66%) ,supporting the fact thatlesions in the left lobe are often symptomatic. Besides this finding, there is a
linear relationship  between  size and symptoms in this analysis, with over 90% of
the patients becoming symptomatic when the lesion is over 15 cm. And
moreover pain abdomen was found to be the predominant symptom which made
the patient to seek medical attention in this study.
All were diagnosed with imaging alone, with CECT being the predominant
diagnostic imaging in our series .
As far as the treatment strategy is concerned ,all the patients werepersistently symptomatic and therefore deserved intervention. Ten out ofeleven patients(10/11 patients) underwent surgery ,either alone or withcombined modality like angioembolisation ,or Sorafenib therapy, particularlyfor a patient who was harbouring a lesion of size (37x19x 15cm),in her rightlobe.
Amongst the surgical options,Resection and not enucleation , was the surgicalmodality employed in this series. The reason being that we could find no welldefined plane of cleavage between the liver parenchyma and the lesion in anyof the patients that we operated. For those surgically high risk group, mereangio embolisation alone could be an safe alternative , which we offered as asole management in a patient who presented with tumour rupture.Angioembolisation stopped the bleeding. Literature also reports no increasein size or any malignant transformation in the lesions that were left behind asremnants after such therapy.
Resection in this series varied between  a simple stapled hepatic resectionwhere the operative blood loss and the duration of surgery were  veryminimal (0.07 litre blood loss,2 hrs 15 min ) to major resection utilizingthoracoabdominal access in the form of median sternotomy ,intrapericardiacIVC control ,(requiring about 14 units of blood , 4.2 litres blood loss andtaking a 7 hour long surgery).
Mortality in this analysis is a patient wherein the liver is found to be fatty andafter resection , bled from the remnant raw area ,wherein we tried withperihepatic packing ,but subsequently she succumbed to multiorgandysfunction after second look laparotomy ,even though raw area has stoppedits bleeding.
Conclusion :
Hemangioma liver can sometimes  be therauptically very challenging .Even
though the indications for intervention are clear ,the  choice of the various
management options must be tailored to the patient’s clinical condition and the
expertise availability.
Complications that can occur in hemangioma may be life endangering
too,sometimes demanding multidisciplinary approach. Offering surgery for those
patients requires a great deal of knowledge and experience in liver resection and
requires a well equipped center with multidisciplinary personnels for successful
outcome in the management of these patients.
.
1INTRODUCTION
Hemangioma is a benign tumour that affects several visceral organs.
Besides the skin which remains the commonest site, the liver happens to be the
commonest visceral organ affected by this vascular tumour .and conversely the
most common benign lesion occuring in the liver is also this hemangioma.
Its occurrence in the liver makes it quite interesting, in that the wide
spectrum with which it presents, manifests, complication it produces, and
technical challenges it can pose while managing it.
Fortunately, almost 90% of the hepatic hemangiomas are asymptomatic
and are incidental in its discovery, in that they are diagnosed during a routine
imaging or for some other cause unrelated to it,and doesn’t cause much
problems throughout patient’s lifespan..
But in a small proportion of patients it can produce symptoms much
enough to necessitate intervention in one form or the other. Besides being
symptomatic, it can occasionally present with complications, well enough to
endanger the life of the affected. Since the lesion is of a vascular one, in many
times the treating physician has to rely on the imaging modalities for arriving at
the diagnosis of this lesion, rather than going for a tissue diagnosis. A variety
of management options are available in the hands of treating physician, such as
2medical, surgical, radiological intervention, radiotherapy. Each one of those
treatment options carries its own pros and cons, and therefore the treating
person needs to have a great deal of vision into the pathological, radiological
and of course in to the management perspectives of this lesion .It not only
requires great deal of knowledge about the disease, but to treat such a
complicated lesion in a comprehensive way, it requires a center where there are
multiple specialities, with profound experience in managing liver disorders. .
ours is one such center where there are multiple specialities operating with a
great deal of knowledge and experience .This study analyses the various pre-
operative, peroperative and post operative variables that tend to occur in
patients with hemangioma, particularly large, symptomatic ones, that we
encountered during the study period,which  could possibly influence the
outcome of these patients.
3AIMOF THE STUDY
To study the different modes of presentation, gender predilection,
symptomatology, complications, various management modalities, , outcome of
these treatment strategies, of patients with Giant Cavernous symptomatic
Hepatic Hemangioma .
4REVIEWOF LITERATURE
Hemangioma represents a congenital, hamartomatous proliferation (Non
–neoplastic ) of vascular origin, arising from mesodermal layer. Its etiology
remains idiopathic. . Skin remains the most common site(1), with the liver
being the most common visceral organ affected..Amonst the lesions that affect
the liver, Hemangiomas tops the list. Its prevalence in the general population is
between 0.4% and 7.3%.(27, 28)
The incidence being increasing now, probably due to the increased no of
patients undergoing . radiologic imaging of the abdomen for other reasons.More
commonly diagnosed between 30 -50 years, they can present at any age.
When considering the gender predilection, it has been found to be 1.3 to 6
times higher in women than in men, (26, 27, 37) thereby, suggest that sex
hormones are somehow implicated in the etio pathogenesis of hemangioma
liver. Although some studies contradicted the issue of female predilection
quoting that, sex hormones have not been etiologically linked to the
development of hemangioma, and autopsy series have reported a nearly equal
sex incidence.(29).
Macroscopically it appears as a well-circumscribed, hypervascular and
compressible lesions with a clear sheath of compressed liver parenchyma
5between haemangiomatous tissue and normal microscopically it appears
as,ectatic blood filled spaces, lined with vascular endothelium and separated by
fibrous septa with a variable sclerotic components of liver. Histological variants
are Fibrolamellar interface, Interdigiting pattern, Compression interface,
Spongy interface.cells stains,and these lesions stain positive for elastin and
trichrome, (1)
SUB TYPES
x Typical hepatic haemangioma
x Atypical Hepatic Haemangioma
x Giant Hepatic Haemangioma
x Flash Filling Hepatic Haemangioma - can account for up to 16% of all
hepatic haemangiomas
x Calcified Hepatic Haemangioma
x Hyalinized Hepatic Haemangioma
Natural history of hemangioma liver :
Majority of the cases are of a incidental discovery rather than a attempted
search for the lesion. Therefore the natural history of the hemangioma are often
asymptomatic and persists throughout the lifespan of the patient . this fact is
6being ablely supported by the fact that majority of the cases are being
discovered during autopsy series (4-7% of incidental autopsy reports)
Only less than 10% of the lesions become symptomatic, and come for
clinical attention .(31)Pain abdomen is the predominant symptom, which draws
the patients to medical person .and that pain is often not so characteristic and
often poorly localized . Pain in hemangioma often remains unexplained in most
of the cases, though thrombosis and infarction of the lesion, hemorrhage into
the lesion, or compression of adjacent tissues or organ have been implicated in
the pathogenesis of the pain in hemangioma liver, (6)
Most of the studies demonstrate a well defined correlation between size
of the lesion and the patient’s presenting symptoms . Goodman noted that
symptoms are experienced by 40% of patients when the lesion is of 4 cm,
whereas with a lesion of well over 10cm, 90% of the patients, they become
symptomatic.(26)
Incidence Of Complications
Even though well over 90% of the hemangioma liver patients remain
asymptomatic throughout their life time, a small percentage becomes
symptomatic and can meet with complications, particularly in those where the
the lesion is quite big in size of the order of more than 10cm .
7The complications listed are
x spontaneous rupture
x Traumatic rupture
x Intratumoural bleeding
And a complication that is unique to this hemangioma –Kassabach –Meritt
Syndrome characterised by consumption coagulopathy and hypofibrino-
genemia, in addition to thrombocytopenia.(26) The reported incidence of this
complication in the literature is about 4%,but it carries about 60-75%
mortality.(22) whereas the operative mortality of a ruptured hemangioma is
about 36.4%(14)
Associated syndromes
The hemangioma is characteristically associated with certain
syndromes .Though rare, these syndromes makes the clinical situation
quite interesting.
Maffucci syndrome, : visceral hemangiomas in the syndrome of
multiple enchondromas and subcutaneous hemangiomas,
Sturge-Weber syndrome (encephalotrigeminal or encephalofacial
angiomatosis): Extensive capillary-venous malformation results in unilateral
cerebral cortical atrophy associated with angioma on the face
8Von Hippel-Lindau disease: A combination of retinal angiomatosis and
angioma that is histologically identical to hemangioblastoma, multiple
hemangioblastomas, pheochromocytoma, pancreatic, renal cysts, renal
tumour, , hepatic lesions,
(Familial cerebro-hepato-renal cavernous angiomas): multiple
cavernous hemangiomas in the liver. angiomatosis of the brain, retina and with
multiple visceral tenangiectasias and cavernous lesions of the skin of the face .
Osler-Weber-Rendau syndrome Multiple dermal, mucosal, and
visceral telangiectasis and arteriovenous malformations
Complications of childhood hemangioma
They are more common in older children and adolescents rather than in
neonates . (20), Presenting as a solitary lesions, mostly seen in the periphery of
the liver.(25)
Usually made as a palpable abdominal mass, sometimes can assume huge
size sufficient to cause cardiac failure (high output cardiac failure) due to
presence of A-V within the tumor (19) Other reported complications in the
paediactric population are
1.Thyroid insufficiency, due to increased production of
iodothyroninedeiodinase(type 3),
92.Hepatic failure,
3.Compartment syndrome,
4.Coagulation abnormalities,
5.Haemolysis,
6. Rupture.
Prenatal diagnosis:
A 16 weeks antenatal scans can be able to bring into light the presence of
such hemangioma which appears as a mixed solid or cystic hypervascular
lesions with punctate calcifications. (15). while before birth they can sometimes
cause compression of IVC thereby producing Hydrops fetalis as one of the
antenatal complications.
IMAGING:
Imaging plays a pivotal role in the diagnosis of the lesion .as the role of
biopsy in the diagnostic workup is controversial and hazardous, it is the imaging
that makes the diagnosis. The various imaging moalities in the armmmentarium
of the hemangioma’s diagnostic workup are USG, CECT, MRI, SPECT and the
newer additions such as Diffusion weighted MRI, and Contrast enhanced USG.
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USG:
Well defined hyperechoic lesions are seen in this imaging modality
however less than 10% are hypoechoic. Particularly when viewed in a fatty
liver. Large lesions can appear heterogeneous because of complex composition.
Posterior acoustic enhancement, sometimes are seen. peripheral feeding vessels
on Doppler may not be seen always.The forementioned appearance is not
characteristic of hemangioma alone., Adenomas, Hepatocellular carcinomas,
and Metastatic disease, all can produce such lesions . However the benign
nature of the hemangioma can be made out with the stable nature of the lesion
upon serial imaging
CECT:
Features of typical lesions include
x Hypoattenuating with respect to liver parenchyma in noncontrast
phase
x Characteristic nodular, peripheral enhancement in arterial phase
(exception- small lesions may show uniform enhancement) -
x Progressive enhancement with centripetal fill in occurring in
portal venous phase -
x Irregular fill in, leading on to iso- or hyperattenuating with respect
to liver parenchyma occurring in delayed venous phase
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The sensitivity of CT in the diagnosis of hepatic hemangioma was
76.92%; specificity, 33.3%; positive prognostic value, 83.3%; and negative
prognostic value, 25.0%. (5)
MRI
Typical features include
T1 - hypointense in relation to rest of the liver.
T2 -intensely hyperintense in relation to rest of the liver . (light bulb
sign)
T1 C with Gadolinium : contrast retention is seen on delayed (>5
minute) contrast images..
One of the useful distinguishing features on MRI is that, whereas both
hemangiomas and malignancies tend to have high signal on conventional T2
weighted images, the signal from malignancies tends to decrease as the time to
echo ratio (TE) is lengthened, whereas the signal from hemangiomas tends to
increase.
MRI, therefore has a reported sensitivity and specificity of greater than
90% and is the imaging modality of choice in many instances.
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USG
less than 1 cm 1 - 3 cm more than 3 cm
Followup MRI CT/RBCS/MRI
SPECT
99Tc RBC labelled SPECT typically demonstrate decreased activity on
initial images followed by increased activity on delayed images .SPECT
significantly improves the sensitivity for hemangioma when compared over
planar imaging, especially for smaller lesions less than 5.0 cm..
DIFFUSION WEIGHTED MRI
The combination of diffusion signal intensity and ADC (Approximate
Diffusion Coefficient) maps and values successfully differentiates
hemangiomas from other focal lesions. DWI mainly useful in distinguishing
between atypical hemangiomas and other lesions e.g. metastatic tumors of
liver.Malignancies have low ADC values and hypointense signal on ADC
maps, whereas hemangiomas do not have low ADC values. (4)
13
CONTRAST ENHANCED USG
Ths imaging modality uses contrast agents like gas microbubbles, which
is coated with surfactant ( polymer like phospholipid or protein). These
microbubble contrast agents are purely intravascular, safe, . These agents are
not excreted by the kidneys, therefore are renal friendly in patients with renal
dysfunction., which is an advantage over CT and MRI ( Hyun-Jung Jang,
Hojun Yu, Tae Kyoung Kim Contrast-enhanced ultrasound in the detection
and characterization of liver tumors Cancer Imaging, 9 (2009), pp. 96–103).
CEUS allows accurate detection of small lesions where CT and MRI fails to
detect. (14)
The characteristic feature of hemangioma in CEUS is perilesional
enhancement ( arterial phase), perinodular enhancement ( portal venous phase)
and, homogeneous to liver on latel phase. The reported sensitivity, specificity,
positive predictive value and negative predictive value of CEUS in hemangioma
were 80%, 100%, 100% and 97.8%, respectively.
TREATMENT INDICATIONS
As already mentioned, the natural history of hemangioma is of a stable
one and in many of the cases, it is often reassurance that is all necessary.
Malignant transformation of the lesion has not been reported. Mere presence of
the lesion in the liver is not an indication for intervention .further, in the absence
of symptoms, however big the lesion, is not an indication for intervention .This
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so happens in a majority of the lesions.(19) An important fact in many studies
regarding hemangioma liver was the absence of growth from the
haemangiomas that were left in the liver remnants after resection.
However in about 10% of the patients, these lesions can assume huge
proportion and can be symptomatic, and therefore deserves intervention.
Besides the persistent symptoms, there are certain absolute and relative
indications for interventions
Absolute indications are
1. spontaneous or traumatic rupture with hemoperitoneum,
2. intratumoral bleeding,
3. consumptive coagulopathy (Kasabach-Merritt syndrome).
whereas relative ones are
1. Persistent abdominal pain,
2. Obstructive jaundice,
3. Portal hypertension,
4. Superficial location of tumors larger than five cm with a risk of trauma,
Uncertain diagnosis(25)
Non indications :
1. Mere finding of the lesion in the liver
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2. Patients anxiety and fear
Size of the lesion in the absence of symptoms or complications
TREATMENTMODALITIES:
Once the patient becomes the candidate for intervention, there are various
options in the armamentarium of interventions. The choice of intervention often
depends on patients clinical condition and location of the lesion .
The various therauptic modalities available for patients with hemangioma
are : steroids, interferon alfa-2 a, embolization, radiotherapy and surgery or
liver transplantation., out of which surgery remains the most consistent
modality of management and was first reported by Hermann Pfannestiel . (39)
Radiation therapy, to some extent expected to produce partial reduction
in size and amelioration of symptoms, but has its own inherent limitations such
as radiation hepatitis, veno-occlusive disease, and hepatoma], therefore the
current status of radiotherapy are only those who are unfit for or refuse surgery, so
also is the hepatic artery embolization .(38)
Steroids have a role in paediactric population but their role in adults
remains questionable..
Radiological Angioembolization should be considered for symp-tomatic
patients in which resection is contraindication or before operation inpatients
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with a ruptured haemangioma, or even in elective cases, to reduce bleeding
during resection
However there are theoretical risk of ischemia of liver and possible
intracavitary bleed or infection with the use of angioembolisation..T he most
characteristic complication with the angioembolisation is the post-embolization
syndrome in the form of pain, pyrexia, leucocytosis and nausea that lasts for a
few days.
Proponents of surgical management quotes the following points
against nonoperative intervention .
With non operative management
1. definite pre-operative diagnosis is difficult to obtain,
2. per-cutaneous biopsy is dangerous
3. and alternative treatment options such as steroids, hepatic artery ligation
and radiotherapy shows controversial results
Therefore surgery remains a promising option still today
The surgical options at hand are
1. Resection,
2. Eunucleation,
3. Hepatic artery ligation,
4. Liver transplantation.
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When surgically feasible, enucleation should be the procedure of
choice, even though at times, one would find it difficult to find out a plane
between the lesion and the adjoining paren chyma, leading to prefer
anatomical resections in most of the situations..
Liver transplantation has also shares in the surgical options available,
wherein there are reports of orthotopic transplantation in in cases of diffuse
hepatic hemangiomatosis and in patients with the Kassabach-Merritt
syndrome,(8)
In the era of target therapy, various bio logical agents has also lended its
helping hand in the management of hemangioma liver. Amonst which there are
reports of resolution of the lesion with the use of Sorafenib, a multiple kinase
inhibitor sed predominantly in various solid tumours . its use is based on the
belief that that abnormal angiogenesis induced by i vascular endothelial growth
factor (VEGF) plays an important role in the causation of hemangioma
Besides Sorafenib, agents like bevacizumab, has also been tried in the
management of hemangioma liver, with promising results, thus opening up new
windows in the management of this lesion. ( 9)
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MATERIALSANDMETHODS
All patients with symptomatic Giant hepatic hemangioma during the
study period from March 2012 to February 2014 were included in the study. The
patients’ demographic data including Name, Age, Sex, place of origin and
occupation were documented. An accurate history taking was done and
recorded systematically.
INCLUSIONCRITERIA:
Only those cases of hemangioma liver who were persistenly
symptomatic and deserved intervention in one form or the other were included
in this analysis.
EXCLUSIONCRITERIA:
Asymptomatic ,incidentally diagnosed ,hemangioma liver were not
included in this analysis.
Variables analysed in this study:
1. Gender predilection
2. Average size:
3. Predominant symptom necessitating intervention
4. compressive symptoms
5. Presenting with complications
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6. Imaging modality clinching the diagnosis most
7. Predominant mode of intervention :conservative/Surgery/ Radiological
intervention/Radiotherapy/Medical /combination of modalities.
8. Resection or eunucleation
9. Resection :Anatomical or nonanatomical
10. Morphology of the tumour:pedunculated/well-defined plane of
cleavage/necrosis/capsular tear
11. Average duration of the surgery :
12. Average blood loss:during parenchymal transection/tumor
mobilization /pedicle control
13. Average amt of blood transfusion/Colloids/Crystalloids.:
14. Inflow pedicle control :pringle/ branch artery ligation
15. Outflow control:intra/extra parenchymal
16. Parenchymal transection: Kelly clasis / bipolar / LIGASURE /
stapler
17. Post op ventilator support:duration
18. Post op inotropes :duration and dose
20. Liver failure: Ser. Bilirubin/INR/Encephalopathy
21. Duration of hospital stay
22. Mortality
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WORKINGCHART
Name Age /sex
Presenting complaints
Pressure symptoms:
Pain
Satiety/vomiting
breathlessness
Pedal edema
jaundice
Bleeding symptoms
Anaemia
Epistaxis
Gingival bleeding
Haematuria
Recurrent abortion
Incidental finding upon evaluation for other causes
PAST HISTORY:
OCP use
Drug intake
Medical illness
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PHYSICAL FINDINGS:
Anaemia
Jaundice
Abdominal mass
Ascites
INVESTIGATION
Hb
Platelet count
Bilirubin
TUMOURMARKER
CEA
AFP
CA19-9
IMAGING
x PORTAL DOPPLER(portal hypertension): yes/no
x USG: CECT: MRI:
x OGD( Varices): yes/no
LESION CHARACTERISTICS
x Size of the lesion
x Site of the lobe
x Unifocal /Multifocal
x Vessel infiltration /compression
x Source of feeding vessels: single/ multiple
22
Management
x Attempted angioembolisation : successful /failed
x Alternative methods employed : medical /RFA/Radiothrapy/
x Surgery: Emergency /elective
Resection :Anatomical/ non-Anatomical
Eunucleation
OPERATIVE DETAILS
x Anaesthesia: GA/Regional /combined
x Position : supine/semiprone
x Incision: midline/Makucchi/subcostal/others
ENERGY DEVICE EMPLOYED
x Monopolar/Bipolar/Kelly clasis/APC /Hydrodissector
x Duration
x Blood loss
x Perioperative events
x Elective ventilation/extubated
POST OPERATIVE COMPLICATIONS
x Liver failure
x Encephalopathy
x Bilirubin returned to normal
x Renal dysfunction
x Respiratory complication
x Discharged on
x Mortality cause
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CERTAIN INTERESTINGCASES
AMONSTTHE ANALYSIS.
CASE NO1:
(ANGIOEMBOLISATION, SORAFENIB AND FINALLY A COMBINED
ABDOMINOTHOACIC APPROACH )
Here is a patient, who presented with a huge symptomatic hemangioma of
size, 33x 19x 15 cm (close to largest of its kind) occupying whole Rt lobe of
liver.She almost had all the possible symptoms that a hemangioma can impose
on a human body such as persistent abdominal pain, breathlessness because of
its pressure upon the diaphragm, besides experiencing trivial bleeding on and
off too.
With a tumour of such a huge size we first decided to manage with Trans
catheter embolization of the feding vessels. Though we could cannulate and
embolise the feeding vessels, we could not appreciate a gross reduction in the
size and symptoms of the lesion, possibly because of multiple feeding vessels.
Then with the evidence from a single case report of a successful
management of a giant hemangioma with SORAFENIB, a multiple tyrosine
kinase inhibitor used primarily in various solid tumours such as hepatocellular
carcinoma, renal cell carcinoma, sarcoma, we tried it with her after getting
consent from her and her family members. But the drug’s severe side effects
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such as dermatologic manifestations, hypertension which is intractable to anti
hypertensive drugs, prevented the drug being continued on her.
Finally after trying these modalities, we planned for surgery .Anticipating
the possible technical challenges it can pose during surgery, we incorporated a
multidisciplinary team comprising cardiothoracic surgeons .
Tumour was approached by a combined abdominal and thoracic access
by employing median sternotomy for gaining access to intrapericardial IVC and
a Makkucchi incision on the abdominal part.it toresok 7 hrs for the tumour to be
resected from the liver by menas of Rt . Hepatectomy, with fourteen units of
blood being transfused preoperatively.patient recuperated well .this case
deserves its place for the stagewise approach and a novel surgical access which
we employed in managing this lesion .
Fig: Angioembolisation
25
Fig : Lesion intraoperatively.
Fig: Median sternotomy.
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CASE NO2 :
A DECEPTIVE ONE AT TIMES- ATYPICAL ONE .
22 yr old female in her 20th day post partum, of an uncomplicated full
term normal delivery, was noticed during her routine post partum check up, by
the attending medical personnel to have an intraabdominal mass, which upon cross
sectional imaging showed up a picture suggesting of a Hepatocellular carcinoma.
CECT revealed a large heterogenously enhancing large necrotic lesion
occupying the segment 5 and 6 of the liver with a large exophytic component.
Serum AFP :1266.32 u/ ml
With the imaging and the Alpha feto protein suggesting that of
Hepatocellular carcinoma, we decided to operate on her since the lesion seemed
to be well resectable with the vessels well away from the lesion and with her
general condition well preserved permitting us for a safe resection. A formal Rt
hepatectomy was done on her, without much trouble and her post op period
was also uneventful. Much to our surprise the biopsy report came as a large
cavernous hemangioma.
Here in her case, the imaging and the ser. marker was found to be
deceptive, in that they both led us to the diagnosis of HCC .However, retrospectively
we could able explain that a raised AFP in a 20 days post partum lady is not
abnormal and that the imaging belonged to an atypical hemangioma, which does
notshow the characteristic enhancement pattern suggestive of hemangioma.
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CASE NO3:
AT TIMES, A SIMPLE ONE TOO.
Heamangioma at times can be a simple one to both diagnose and to
manage, wherein a lt lobe hemangioma of size 9x7 cm was resected with the
help of vascular staplers(Stapled hepatectomy) over a period of just 20
minutes(transection part) with no per or post operative complications
henceforth.this case in our series is the one with least blood loss, duration,
transfusion requirements, and duration of post operative stay .
Fig: Stapled hepatectomy.
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CASE NO4: RESECTION LED TO POST OP LIVER FAILURE.
60 Yr . old female compounded by diabetes and hypertension  as
comorbid illnesses, presented with a symptomatic hemangioma of 19x 16 x 12
cm occupying the left lobe of the liver, compressing the left branch of the
portal vein .
The patient demanded extensive cardiac work up and optimization, so as
to forfeit any cardiac catastrophe or any metabolic complication arising out of
her impaired glycaemic status and compromised cardiac condition. A formal lt
hepatectomy done on her, after optimization of her medical condition was an
uncomplicated one, but the crux of the problemwas her post operative course.
Patient went on for altered mentation in her third post operative day
onwards .Being a diabetic patient we went on to have a metabolic cause for this
clinical situation .But with her blood glucose and her electrolytes within the
normal range, and the patient on oral alimentation from the second post
operative day, and with her bilirubin and her international normalized ratio on
the rise, we knew that she was on the diagnosis of post operative liver failure .
Her Ser. Ammonia level was in the higher range of the order 69 with the
reported lab range (5 -30)., we started managing her with sugar free lactitol,
Branched chain aminoacids, lactulose enema, correction of hypokalemia,
removing all the intravenous lines that could be a source of infection which
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could potentiate POLF.Towards the end of the first week, her mentation
returned towards normalcy, and her biochemical profiles came to normal,
suggesting that her liver started meeting the demands of the body’s metabolic
demand.
CASE NO :5
HEMANGIOMAWHEREIN WE LOST THE PATIENT
A 12x 9 cm hemangioma in the segment 6 and 7 in a 57 yr old diabetic,
who weighed 84 kg with her BMI of the mildly obese, who was operated for
her worsening symptoms of abdominal pain and breathlessness. Patient’s
cardiorespiratory, glycaemic condition, coagulation status were extensively
worked up preoperatively, and optimized well before embarking on surgery.
Peroperatively after abiding to the simple rules of liver resection
(adequate inflow ), the resection part was not a tough one, but what made all the
things worse was the texture of the remnant liver, which was fatty and was
bleeding from its raw surface, refractory to all the available energy devices
(monopolar, bipolar, APC), forcing us to pack it all around and then optimize
the patient over a period of 48 hrs.
We reopened and unpacked and found that the bleeding has responded to
the perihepatic packing, but the patient could not tolerate the insult of two
laparotomies, anaesthesia, metabolic derangements, and the brunt of blood
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transfusions. Her renal function deteriorated, with acidosis, deranging her
respiratory status and finally she succumbed to multiorgan dysfunction .
CASE NO 6:
RUPTURED AT PRESENTATION, BUT MANAGED TO SURVIVE, BY
ANGIOEMBOLISATION.
An odd male in this analysis is this patient, who was referred to our
tertiary care hospital from a place which is somewhere around 5 hrs from our’s
in a state of compensatory shock, with tachycardia, BP 100/60, and with clinical
signs of pallor, with a imaging showed features of bilobar liver lesions with its
characteristic enhancement pattern, and evidence of capsular breach at one
point .
We could resuscitate the patient and could make him hemodynamically
stable overnight, thereby he was angioembolised, the next morning .The
procedure went on well with successful cannulation of the feeding vessel
.Immediately his hemodynamic status responded, and he recuperated
well.Though the post procedural imaging failed to show any gross reduction in
the size there was not much contrast blush in the lesion with capsular breach.
The Patients symptoms also subsequently subsided, but unfortunately patient
was not willing for any form of treatment and therefore went on.
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RESULTS
1 Sex predilection Female(90.9%)
2 Median age of presentation 40 yrs
3 Age range 22-60yrs
4 Predominant symptom Pain abdomen
5 OCP usage no
6 Predominant clinical presentation Abdominal mass
7 Predominant pressure symptoms breathlessness
8 Anaemia 18.18%
9 Thrombocytopenia 1
10 Coagulopathy 1
11 Tumour marker(AFP) 1
12 Portal hypertension none
13 OGD finding Extraneous imp.
14 Imaging modality that made the diagnosis CECT
15 Imaging modality that predicted the tumour
size well
CECT
16 Lesion more than 10 cm 67%
17 Lesion more than 15 cm 33%
18 Rt lobe 33.33%
19 Lt lobe 66.66%
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20 Exophytic lesion 25%
21 Atypical Hemangioma 9.09%
22 Observation 0%
23 Intervention 100%
24 Eunucleation 0%
25 Anatomical resection 80%
26 Non anatomical resection 20%
27 Angioembolisation 16.66%
28 Combination of intervention 9.09%
29 Avg duration of surgery 3 hrs.15min
30 Avg amount of blood loss 1087 ml
31 Avg. blood transfusion 3.36 units
32 Predominant method of inflow control Pringle
33 Predominant method of transaction Kelly clasis
34. Raw area managed with Suture ligation
35 Extubation or elective ventilation 81.81%
36 Duration of analgesia 4.1 days
37 Oral resumption 2.5 days.
38 Heparinisation 81.81%
39 Ambulation 4.1
40 Duration of post operative period 19.81
41 Mortality 1
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DISCUSSION
Haemangioma liver, of course a rare condition, can be innocuous in
most of the times, but sometimes can be troublesome and be challenging to the
treating surgeon .In this analysis, only those cases that are huge and persistently
symptomatic, and those with complications, who underwent intervention alone
were analysed.
1. Age:
The median age of presentation in this analysis was 40 yrs, with the
range being 22 to 60yrs.
2. Gender distribution
Importantly the sex predilection in this analysis is predominantly females
in the proportion of 90%to 10% (M:F) However none of the female patients
gave a history of OCP usage, thus raising the question of the influence of the
hormonal factors in the pathogenesis of this lesion, Probably some other female
factorsmight be incriminated in the etiopathogenesis of the lesion.
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3. Distribution of the lesion within the liver (Rt lobe or Lt lobe):
The majority of the lesions in this analysis were found to be arising from
the Lt lobe of the liver, thereby supporting the literature evidence that, Lt lobe
lesions though somewhat less common in incidence when compared to Rt lobe,
are often symptomatic and thereby deserves intervention, more than that
occurring in the right lobe.. The incidence of Lt lobe lesions in this study is
66.66% whereas the Rt lobe lesions constitute 33.33%, thereby one again
reiterating the fact that Lt lobe lesions are often symptomatic.
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Fig: Distribution within the Liver.
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4.Size Vs Symptoms
Also the symptoms correlated well with the tumour size in this analysis,
that is only those lesions, that were more than a critical size of the order 8cm or
more were associated with persistent symptoms, and came for medical
intervention . Interestingly, three(3/11cases) of the patients who were
harbouring lesions that were more than 15 cm, not only were symptomatic, but
met with complications also.
Patient no 1:. Experienced chronic form of coagulopathy(Kassabach –
Meritt Syndrome)
Patient no2:developed Post operative liver failure
Patient no 3:developed peroperative bleeding, died after we attempted
with perihepatic packing.
Therefore, size of the lesion in this analysis proved to be an important
factor affecting the outcome in treating these lesions.
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Even though literature stresses the fact that size of the lesion is not the
one which demands intervention, majority of the patients who were harbouring
lesions of the order of 15 cm, invariably will be persistently symptomatic and
thereby merit intervention in one form or the other.
5.Predominant symptoms:
As far as the symptoms in this analysis are concerned, the predominant
symptom for which they seek the medical attention is the persistent upper
abdominal pain.(91.66%). Though the pain in these patients were rarely severe
and often dull achey and poorly localized, it remains the predominant mode of
presentation for which they were subjected to imaging, which brings the lesion
to the surgeon’s notice.Besides pain, two of the patients also experienced the
complications that could arise in this lesion. One patient developed a chronic
38
form of hemolysis and persistent low platelet count (Kassabach-Meritt
Syndrome), and she also developed breathlessness, due to pressure effect on
the diaphragm, restricting its movement, thereby developing breathlessness,
more so when she lies down., apart from suffering from bleeding complications
such as repeated abortion and gingival bleeding, and another one presented with
acute form of complication, tumour rupture and with hemodynamic compromise.
6.Clinical examination :
Clinically all the patients presented with palpable abdominal mass, which
is non tender, confined mostly to upper abdomen, continuous with liver
dullness, along with pallor which we could be able to make it out in two
patients and jaundice in one patient which is of the order of 4.0 gms, and is non-
obstructive in nature, we could explain it as she was also experiencing a chronic
form of mild hemolysis, and also intratumoural bleeding.
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The blood investigation of these patients are not much informative and
conclusive except for the anaemia, and low platelet count .Tumour markers in
these patients were analysed in this study. we could manage to do serum AFP,
CEA and CA19-9 in all these patients .None of the tumour markers were
elevated except in one patient who is 1 month post partum and with elevated
AFP of the order of 1266.32 units/ ml .interestingly her imaging also does not
show the characteristic enhancement patten of the hemangioma, thereby we
were entertaining the diagnosis of Hepatocellular carcinoma in her.per
operatively the lesion was found to be hemangioma, which was very much
confirmed by the biopsy from the resected specimen.
7.Imaging :
Not only the patients included in this study, but also almost 80% of the
patients referred to our department, were with imaging of one type or the other
related to the clinical condition . In this way the patients in this study were with
either one or more of the following imaging modalities( USG, CECT, MRI) .
Amongst the imaging modalities cited, the CECT is the one which made the
diagnosis primarily in over 90% of the cases is CECT .CT –angio was taken in
one case, which could add the information about the relation of the lesion with
the vessels.
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imagingmodalities .
100%
90%
80%
70%
60%
50%
40%
30%
20%
10%
0%
90.09%
0% 0%
9.09%
imaging modalities .
USG alone USG +CECT USG +CECT
+MRI
USG
+CECT+MRI
+CT- Angio
Fig : CECT of hemangioma Liver (Characteristic peripheral puddling Sign) .
Fig: MRI in one of our patient showing Giant hemangioma
occupying the entire Rt lobe
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Fig : The same patient’s CT- angio (demonstrating multiple feeding vessels) .
Also in this study, we could make out that, the lesion size found
intraoperatively correlated well with the size made out at CECT, rather than
with USG, thereby inferring about the diagnostic superiority of the CECT than
with USG.We could not compare the diagnostic superiority of the MRI with
CECT, because majority of the patients were analysed only with CECT, without
moving on to MRI.
But the CECT failed to diagnose the atypical nature of some of these
giant hemangioma, which became evident in one case of 22 yr old female and
is 2 weeks post partum with raised AFP levels (1266.32), which in the absence
of the characteristic contrast enhancement, was given the impression of
Hepatocellular carcinoma, which when operated found to be a case of giant
atypical hemangioma. The post partum state masqueraded the condition by
causing pseudoelevation of AFP.
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8. Tumour morphology:
As far as the tumour morphology is confirmed, three out of eleven lesions
were exophytic in nature, and in none of the cases wherein we could
demonstrate a interface between the lesion and the parenchyma.
This could be the main reason for which none of the patient were offered
eunucleation as a surgical treatment of choice.
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9. Intervention:
Amongst the intervention, all but one patient included in this study
underwent surgery. The odd patient who presented with ruptured hemangioma
managed to survive with angioembolisation, and further refused surgery and
went on after stabilization.
Mode of intervention
Surgery alone: 81.81%
Angioembolisation alone : 9.09%
sorafenib therapy alone: 0%
Combination (Surgery+
Angioembolisation +Sorafenib therapy): 9.09%
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10. Surgical intervention :
surgical interventions
100%
100%
80%
60%
40%
20%
0%
Resection
0%
Eunucleation
0%
hepatic
arteryligation
surgical interventions
The rest of the patients underwent surgical intervention either in the form
of anatomical or non anatomical liver resection
Anatomical liver resection : 80%
Non anatomical liver resection : 20%
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But, none of our patients were offered eunucleation as a surgical
modality, because of the absence of well defined plane of cleavage between the
lesion and the liver parenchyma. This is in contrast to the literature, wherein
there often will be a plane of cleavage between the lesion and the liver
parenchyma
11.Intraoperative parameters:
Apart from these observations, there are quite a few intraoperative
parameters that became evident in this retrospective study.
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12.Blood Loss and transfusion requirements:
The average amount of blood loss in the resection were 1087 ml with the
maximum loss(4200ml) noted in patient with giant lesion of size 37x19x15 cm
with 14 units of blood transfusion, and the least amt of 70 ml noted in
laparoscopic hepatectomy, with no blood transfusion. But for that, all patients
were transfused with an average amount being 3.36 units.
47
13.Duration of surgery:
The Average duration of surgery being 3Hrs. 15 min, with maximum
time taken being 7 hrs.(who underwent median sternotomy) and the minimum
being 2 hrs. 15 minutes (Stapled resection ).
Stapled resection :2 hrs. 15 min
Abdomino thoracic:7 hrs.
Average :3 hrs. 15 min.
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14.Technique of Hepatectomy:
The predominant mode of inflow occlusion is the pringles maneovre, and
in no cases were the branch artery were ligated before proceeding on to
parenchymal transection, probably the lesion overhanged the hilum in most
lesions thereby leaving little room for the operating surgeon to get hold of the
branch vessels over there(8/11 cases- 72.72%.) .one patient stopped short of
angioembolisation and did not proceed on for surgery, and in the one who
underwent stapled hepatectomy, transection was done without gaining inflow
control, and the third one also underwent Lt hepatectomy (Hanging lesion from
the Left lobe ), without formal inflow control.
Parenchymal transection in all the cases, were done with a combination of
Kelly clasis and monopolar diathermy(10/11 cases-90.09%) . harmonic was
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added in three cases along with Kelly clasis and monopolar cautery (27.27%).
hydrodissector (WATERJET) was employed in three cases along with the
forementioned transection methods (27.27%).
15.Transectionmethods
Kelly classis alone 0%
Kelly classis+Diathermy 63.63%
Kelly +diather+harmonic 27.27%
Kelly +Diatherm+waterjet 27.27%
Vascular stapler 9.09%
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16.Management of Raw area:
Hemostasis in the raw area managed with suturing with 000 silk in 10out
of 11 operated cases(90.9%).Besides suture ligation the raw area in the remnant
liver is managed with Argon Plasma Coagulator(1/11 case-9.09%),
surgiseal(2/11 cases-18.18%), and tissue seal(FIBRIN)-1/11( 9.09%) case .the
parenchyma is transected with the combination of Kelly clasis and diathermy.
Suture alone 63.63%
Suture +APC 9.09%
Suture +Surgiseal 18.18%
Suture+Fibrin 9.09%
The odd patient in this analysis whom we lost after perihepatic packing
was the one I whom the bleeding from the raw area failed to respond to these
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agents, thereby we attempted to optimize the situation by perihepatic packing
and then the patient underwent relaparotomy after 48hrs. Even though the
bleeding from the raw area responded to the perihepatic packing, patient
subsequently developed sepsis, and multiorgan dysfunction leading to death,
the only reported mortality in this analysis.
Fig:Raw area managed with sutures .
Fig: With Argon Beam Coagulation.
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Fig : with Surgiseal.
Fig: With Tissue sealant (FIBRIN GLUE)
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19.Immediate post operative course:
All the operated patients except two (2/11 cases), were extubated,
immediate post operatively and were managed in the ICU for an average of one
day and were shifted to post operative ward.
Post operative course:
All the operated patients received anticoagulation (heparin) in the post
operative period (81.81%), except two patients wherein because of their
bleeding we did not attempted heparinisation in them .the two patients were the
one whom we angioembolised, and the other one whom underwent perihepatic
packing.the average duration duration of days of hepaininsation was found to be
2.4 days.
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The one (perihepatic packing )for an average period of 2.4 days, till they
are ambulant.
oral resumption was on an average of 2.5 days .The earliest one to resume
oral alimentation was the one who underwent stapled resection. Analgesics are
mostly continued for an average period of of 4.1 days, mostly with epidural
Analgesia (lignocaine, Tramadolol) to start with and to taper with oral
tramadolol. Again the patient who underwent median sternotomy required a
maximum duration of analgesics, whereas the one who underwent stapled
resection required the least duration in this analysis.
Almost all the patients were discharged after suture removal, that is on
the 9 -11 POD, with an Avg of 19.81 days, as the two patients, one who
underwent abdominothoracic approach and the one who had post operative liver
failure had a prolonged post operative stay.
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Duration of post operative stay(days)
20 18
18
16
14
12
10 Duration of post operative
8 stay(days)6
6
4
2
0
abdominothoracic stapled resection
Mortality in this analysis was one patient who bled from the raw area of
the remnant liver due the fatty nature of the liver and was initially managed with
anged with perihepatic packing and then underwent relaparotomy and then
developed multiorgan dysfunction and death.
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CONCLUSION
Hemangioma liver, though highly prevalent amongst the population and
often diagnosed as a a incidental finding during imaging, the symptoms and the
complications arising out of the lesion are quite rare.when symptomatic, the
lesions are always quite large, much bigger than what the literature quotes as a
giant hemangioma (>4cm).Distinctively, the lesions associated with
complications are much larger than the lesionswhich are persistently
symptomatic. Even though literature quotes that the size of the lesion is not the
criteria for undertaking intervention, larger hemangiomas are invariably
associated with persistent symptoms and of course with complications. This is
evident in this analysis, in which there is linear relationship of size with
symptoms.
Undoubtedly, hemangiomas are common in female gender, however the
reason for this female predilectionstill remains unravelled. The role of chronic
OCP usage in the etiopathogenesis of the hepatic hemangioma is not well
established as that of the case of Hepatic adenoma, but still there are reports of
hemangioma liver increasing in size upon the effect of progesterone during
pregnancy.. In this analysis we too have encountered a case of hepatic
hemangioma in a twenty days old post partum .probably the lesion would have
increased in size throughout the pregnancy upon the influence of progesterone.
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This female predilection and the influence of the female hormones needs further
appraisal in this regard.
The absolute and the relative indications of intervention for giant
hemangioma are well established.And the role of conservative approach for
incidentally diagnosed lesion is also well established. Though the role of CECT and
MRI in the diagnosis of classical hemangioma is undoubtedly evident, with atypical
hemangioma, wherein the classical enhancement pattern of the hemangioma will
not be present, the role of Contrast enhanced USG, and the Diffusion weighted
MRI has to be established. With these imaging modality able to pick up both
typical and atypical variants of the hemangioma, the role of preoperative biopsy is
not only needed, but also catastrophic and is ruled out nowadays.
Amongst the interventions, Surgery clearly has got an edge over others
in patients for whom the risk of surgery is low. But even in such patients, where
the lesion is too large much similar to what we encountered in this analysis, one
could adopt a rather stepwise approach  like an initial angioembolisation
followed by surgical intervention seems to be an attractive option .
For patients whom the surgical risk is too high, therauptic
angioembolisation alone could be an safest approach, since malignant
transformation in hemangioma liver is unknown and unheard of, and therefore
the lesion can be best left as such.
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And there are reports of target agents in the therapy of hemangioma liver
too, such as Sorafenib and Bevacizumab based on the fact that the growth of
the lesions were influenced by VEGF.
Eventhough the literature advocates eunucleation as a preferential
surgical modality than resection, because it allows for a greater preservation of
liver parenchyma, leaving behind minimal morbidity, no patient were offered
eunucleation in this series, as there was no well defined plane of cleavage
between the lesion and the parenchyma.
The principles of resection in hemangioma liver is the same as in standard
hepatic resection, that is adequate inflow and outflow control
But the surgical resection demands a high degree of surgical expertise
and a great deal of knowledge in hepatic resections, and invariably requires well
equipped center and a multidisciplinary personnels for successful outcome of
the procedure.
Studies were able to establish the fact that the left over lesions after
resection remains as such and does not grow subsequently, reveals that no long
term follow up is needed for these patients who were offered treatment in form
or the other for these giant symptomatic hemangioma .
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Name Age. Sex Presenting symptoms compressive symptoms bleeding diatheses OCP intake comorbid illnesses
satiety jaundice dyspnoea gingival bleeding abortion
Zareena 34 f pain-abdomen no no yes yes yes no no
jebamalai 60 f pain-abdomen no no no no no no Diabetic/HT
vinodhini 22 f pain-abdomen no no no no no no Postpartum
kandasamy 40 m shock no no no no no no no
laxmi 35 f pain-abdomen no no no no no no no
kalaivani 53 f pain-abdomen no no no no no no Diabetes
kasiammal 42 f pain-abdomen yes no no no no no no
mariammal 38 f pain-abdomen no no no no no no HBSAg
mohana 43 f pain-abdomen no no no no no no no
Dhanalaxmi 39 f pain-abdomen no no no no no no no
Murugayee 54 f pain abdomen no no no no no no diabetic
MASTER CHART
Name Pallor Jaundice Dyspnoea Easy bruisability Abdominal mass Ascites Meleana Hb Bilirubin PT/INR AFP Platelet count
Zareena yes yes yes no yes minimal no 6.8 3.2 14.4/1.02 0.5 0.68
jebamalai yes no yes no yes no no 10.6 3.2 17.4/1.29 no 2.21
vinodhini no no no no yes no no 9.5 1 13.6/1.02 1266.32 6.42
kandasamy yes yes yes no yes yes no 5.9 4.2 12.8/1.01 no 1.78
laxmi no no no no yes no no 9.4 0.9 12.7/.94 1.42 1.47
kalaivani no no no no yes no no 8.2 0.6 13.1/.98 2.04 1.64
kasiammal no no no no yes no no 12.8 0.6 12.7/0.9 2.1 1.68
mariammal no no no no yes no no 9 0.7 12.7/0.9 1.2 1.42
mohana no no no no yes no no 10.2 0.8 13.2/.9 1.59 2.58
Dhanalaxmi no no no no yes no no 9.5 1 13.9/1.00 0.74 1.31
Murugayee no no no no yes no no 10.2 1.1 12.8/1.00 1.1 1.55
Name OGD first imaging done USG size CECT impression MRI impression CT Angio Rt .lobe Lt lobe exophytic At Surgery
Zareena Extraneous imp. DI CECT 22.8x14.6x26.7 cm 33x19x15 cm 24X14X20 cm 29x16x14 yes no yes 35x20x15 cm
jebamalai Extraneous imp. DI CECT 16x12cm 19x16x 12.6cm not done not done no yes yes 20x25cm
vinodhini Extraneous imp. in DI USG 9x6 cm 9x7x6 cm not done not done yes no no 11x10cm
kandasamy not done CECT 14x12 cm 15x15 cm not done not done yes no no not operated
laxmi Extraneous imp. DI CECT 9.8x7.1 cm 9.7x9.8x10cm not done not done no yes no 10x10 cm
kalaivani Normal CECT 8x8 cm 9x 7.8 cm not done not done yes no no 15x12 cm
kasiammal LaxLES USG 10x12 cm 13.5 x 9 cm not done not done no yes yes 13x 13 cm
mariammal Distal Esophagitis USG 9x8 cm 11x 12 cm not done not done no yes no 11x11 cm
mohana normal study CECT 10x 8.8 cm 7x6.5x6 not done not done no yes no 9x7 cm
Dhanalaxmi normal study CECT 9.8 X 8 cm 8x6 cm not done not done no yes no 7x6cm
Murugayee normal study USG 11.8x7.5 9x7x6 cm not done notdone no yes no 10x8cm
Name Observation Intervention
surgery Angioembolisation Sorafenib Others
Zareena no yes yes yes no
jebamalai no yes no no no
vinodhini no yes no no no
kandasamy no no yes no no
laxmi no yes no no no
kalaivani no yes no no no
kasiammal no yes no no no
mariammal no yes no no no
mohana no yes no no no
Dhanalaxmi no yes no no no
Murugayee no yes no no no
Name Inflow occlusion parenchtmal transection Raw Area treated with packing Duration of Surgery Blood loss TRANSFUSION
Pringle Branch ligation kelly clasis Diathermy Harmonic Stapler waterjet Suture Surgiseal APC tissue seal no Blood Colloids FFP
Zareena yes no yes yes no no no yes no yes no no 7 hrs 4200ml 14 2 11
jebamalai yes no yes yes yes no no yes yes no yes no 4 hrs. 20 min 1000 ml 4 1 4
vinodhini yes no yes yes yes no no yes no no no no 3 hrs. 1000ml 2 2 3
kandasamy not operated not operated not not not no not not not not not no not operated not 3 no 4
laxmi no no yes yes no yes no yes yes no no no 2 hrs. 15 min 70 ml 0 0 0
kalaivani yes no yes yes yes no no yes no no no yes 3hrs 900ml 2 0 2
kasiammal no no yes yes no no yes yes no no no no 2 hrs 40min 1200ml 3 1 4
mariammal yes no yes yes no no yes yes no no no no 3 hrs 50 min 750 ml 3 1 4
mohana yes no yes yes no no no yes no no no no 550 2 1 4
Dhanalaxmi yes no yes yes no no no yes no no no no 600 2 1 4
murugayee yes no yes yes no no yes yes no no no no 3 hrs 600ml 2 1 3
name VENTILATION inotropes heparin upto oral resmptionpain killers EncephalopaBile leak post op stay
Zareena yes yes 4 days Day6 7 days no no 18 da ys
jebamalai extubated no 4days day4 5days yes no 16 days
vinodhini extubated no 4days day2 3 days no no 7 days
kandasamy no yes no no 2 days no no 12 days
laxmi extubated no 2 days day2 2 days no no 6 days
kalaivani extubated yes no no 3 days no no expired
kasiammal extubated no 2 days day2 5 days no no 10 days
mariammal extubated no 2 days day2 5 days no no 10 days
mohana extubated no 2 days day3 5days no no 7 days
Dhanalaxmi extubated no 2 days day2 5 days no no 7 days
murugayee extubated. no 2 days day2 5 days no no 10days
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CONSENTFORM
Information to Participants
Title: -
“Giant Hepatic Hemangiomas – Analysis of presentation, ,management and
outcome – our experience
Principal Investigator: DR. M. GNANASEKAR
Co-Investigator(if any):
Name of Participant:
Site :
You are invited to take part in this research/ study/procedures/tests. The information in this document is
meant to help you decide whether or not to take part. Please feel free to ask if you have any queries or
concerns.
What is the purpose of research?
To study the sex predilection ,presenting symptoms ,predominant management options ,complications
,outcome of these management options of the patients with giant symptomatic hemangioma liver
We have obtained permission from the Institutional Ethics Committee.
The study design
Retrospective study
Study Procedures
The study involves evaluation of giant ,symptomatic hemangioma for which we will need tumor
markers, USG,UGIscopy , CECT Abdomen  & Pelvis. The planned scheduled involve visits at
, , _,
and (days/ weeks) after your initial visit. You will be required to visit the hospital
number of times during the study.
At each visit, the study physician will examine you. Some [blood / urine /imaging/clinical examination
other] tests will be carried out at each visit. [… … ml of blood will be collected at each visit. Blood
collection involves prick with a needle and syringe.] These tests are essential to monitor your
condition, and to assess the safety and efficacy of the treatment given to you.
In addition, if you notice any physical or mental change(s), you must contact the persons listed at the
end of the document.
You may have to come to the hospital (study site) for examination and investigations apart from your
scheduled visits, if required.
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Possible risks to you – If any, Briefly mention
Possible benefits to you - If any, Briefly mention
Possible benefits to other people
The results of the research may provide benefits to the society in terms of advancement of medical
knowledge and/or therapeutic benefit to future patients.
Confidentiality of the information obtained from you
You have the right to confidentiality regarding the privacy of your medical information (personal
details, results of physical examinations, investigations, and your medical history). By signing this
document, you will be allowing the research team investigators, other study personnel, sponsors,
Institutional Ethics Committee and any person or agency required by law like the Drug Controller
General of India to view your data, if required.
The information from this study, if published in scientific journals or presented at scientific meetings,
will not reveal your identity.
How will your decision to not participate in the study affect you?
Your decision not to participate in this research study will not affect your medical care or your
relationship with the investigator or the institution. You will be taken care of and you will not loose any
benefits to which you are entitled.
Can you decide to stop participating in the study once you start?
The participation in this research is purely voluntary and you have the right to withdraw from this study
at any time during the course of the study without giving any reasons. However, it is advisable that
you talk to the research team prior to stopping the treatment/discontinuing of procedures etc.
Signature of Investigator Signature of Participant
Date Date



